178 related articles for article (PubMed ID: 2554513)
21. The neutropenia of Felty's syndrome.
Bishop CR
Am J Hematol; 1977; 2(2):203-7. PubMed ID: 329671
[No Abstract] [Full Text] [Related]
22. Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.
Figueredo AT; Hryniuk WM; Strautmanis I; Frank G; Rendell S
J Clin Oncol; 1985 Jan; 3(1):54-64. PubMed ID: 2981292
[TBL] [Abstract][Full Text] [Related]
23. Combined therapy of G-CSF and prednisolone for neutropenia in a patient with Felty's syndrome.
Toshioka K
Am J Hematol; 1995 Feb; 48(2):130-1. PubMed ID: 7531393
[No Abstract] [Full Text] [Related]
24. Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study.
Livingston RB; Crowley JJ; Thompson T; Williamson SK; Meyers FJ; O'Rourke T; Neefe JR
Cancer; 1993 Jun; 71(11):3509-13. PubMed ID: 8387881
[TBL] [Abstract][Full Text] [Related]
25. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
[TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy of small cell lung cancer].
Komiya T; Takada M
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
[TBL] [Abstract][Full Text] [Related]
27. Granulopoietic activity in Felty's syndrome.
Gupta R; Robinson WA; Albrecht D
Ann Rheum Dis; 1975 Apr; 34(2):156-61. PubMed ID: 49177
[TBL] [Abstract][Full Text] [Related]
28. The importance of dose and dose intensity in lung cancer chemotherapy.
Murray N
Semin Oncol; 1987 Dec; 14(4 Suppl 4):20-8. PubMed ID: 2825357
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of treatment of recurrent small-cell lung cancer.
Hosp Med; 1999 Mar; 60(3):220. PubMed ID: 10476252
[No Abstract] [Full Text] [Related]
30. Felty's and pseudo-Felty's syndromes.
Rosenstein ED; Kramer N
Semin Arthritis Rheum; 1991 Dec; 21(3):129-42. PubMed ID: 1788550
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporine for the treatment of granulocytopenia in Felty's syndrome.
Canvin JM; Dalal BI; Baragar F; Johnston JB
Am J Hematol; 1991 Mar; 36(3):219-20. PubMed ID: 1996561
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of 2 regimens of chemotherapy of small cell carcinoma of the lung: modified Hansen method and the ACOM method].
Jassem J; Karnicka-Młodkowska H; Mierzewski P; Decker E; Krawczyk K; Lisowska B; Malak K; Słupek A; Sokół A; Sosnowski K
Pneumonol Pol; 1988 Apr; 56(4):142-51. PubMed ID: 2842737
[No Abstract] [Full Text] [Related]
33. Small cell lung cancer and chemotherapy.
Nardini S
Monaldi Arch Chest Dis; 1994 Apr; 49(2):178-9. PubMed ID: 8049707
[No Abstract] [Full Text] [Related]
34. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
35. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
36. Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG.
Fiechtner JJ; Miller DR; Starkebaum G
Arthritis Rheum; 1989 Feb; 32(2):194-201. PubMed ID: 2920054
[TBL] [Abstract][Full Text] [Related]
37. Coexistent Felty's syndrome and palindromic rheumatism.
Alvillar RE; O'Grady L; Robbins D
Ann Rheum Dis; 1991 Dec; 50(12):953-5. PubMed ID: 1768169
[TBL] [Abstract][Full Text] [Related]
38. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
[TBL] [Abstract][Full Text] [Related]
39. Treatment of small cell lung cancer with cyclophosphamide, adriamycin and vincristine (CAV) combination therapy: experience at University Hospital, Kuala Lumpur, Malaysia.
Lee SM
Singapore Med J; 1990 Aug; 31(4):317-20. PubMed ID: 2175049
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic results in the treatment of small cell bronchial cancer: experience of the EORTC Lung Cancer Working Party (Belgium)].
Sculier JP
Bull Cancer; 1987; 74(5):565-8. PubMed ID: 2825858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
